Code42 to Showcase Insider Threat and Source Code Protection at RSA Conference
April 23, 2024 08:00 ET
|
Code42 Software, Inc
Code42 team to host conversations about how to mitigate data loss and protect source code without hindering productivity or burdening security teams.
ORIGENCE ANNOUNCES LENDING TECH LIVE SPEAKERS TO INCLUDE LEADERS FROM MICROSOFT, EXPERIAN, CATALYST, AND MORE
April 23, 2024 06:00 ET
|
Origence
Irvine, California, April 23, 2024 (GLOBE NEWSWIRE) -- Origence, the leading lending technology solutions provider for credit unions, announces breakout session speakers for its Lending Tech Live...
South Street Securities Holdings, Inc. Celebrates Earth Day in Partnership with Evertreen
April 22, 2024 09:50 ET
|
South Street Securities Holdings, Inc.
New York, April 22, 2024 (GLOBE NEWSWIRE) -- In celebration of Earth Day, April 22, 2024, South Street Securities Holdings, Inc. (“South Street”) is pleased to announce its continued partnership...
NH Community Health Worker (CHW) Summit Convenes on April 30
April 22, 2024 09:13 ET
|
North Country Health Consortium
Littleton, NH, April 22, 2024 (GLOBE NEWSWIRE) -- Over 150 Community Health Workers (CHWs), healthcare providers, social workers, policymakers, and state agencies will come together on April 30,...
NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes and Regenerative Medicine
April 19, 2024 16:04 ET
|
NurExone Biologic Inc
NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at top European Conference on Exosomes and Regenerative Medicine
Unveiling the 8th Future Investment Initiative’s theme: "Infinite Horizons: Investing Today, Shaping Tomorrow"
April 17, 2024 17:08 ET
|
FII Institute
FII Institute is excited to announce the theme for its upcoming 8th edition of the FII conference, scheduled for October 29-31, 2024.
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
April 17, 2024 07:25 ET
|
ALTERITY THERAPEUTICS LIMITED
– ATH434 Improved Motor Performance and General Function in a Primate Model of Parkinson’s Disease – – ATH434-201 Phase 2 Baseline Data Confirm Approach to Target Biomarkers for Slowing...
Sezzle to Participate in Upcoming Investor Conferences
April 16, 2024 16:23 ET
|
Sezzle
Minneapolis, MN, April 16, 2024 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, today announced that the Company’s management...
Bloomage Showcases Bioactive Substance Innovations and Sustainability Commitment at China International Consumer Products Expo
April 15, 2024 09:00 ET
|
Bloomage Biotech
Parsippany, New Jersey, USA, April 15, 2024 (GLOBE NEWSWIRE) -- Bloomage, a global company specializing in hyaluronic acid and other bioactive substance innovations, has attended the China...
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami
April 15, 2024 08:00 ET
|
London Research and Pharmaceuticals
London Research & Pharmaceuticals Corp. Presents the Advancement of their Oral Cannabidiol Sulphate Drug Candidate at Epilepsy Therapies Conference